Medicinal Bioprospecting: Policy options for access and benefit-sharing

DSpace/Manakin Repository

Show simple item record

dc.contributor.author SMAGADI, Aphrodite
dc.date.accessioned 2012-09-27T13:03:11Z
dc.date.available 2012-09-27T13:03:11Z
dc.date.issued 2009
dc.identifier.citation London, British Institute of International and Comparative Law, 2009 en
dc.identifier.isbn 9781905221363
dc.identifier.uri http://hdl.handle.net/1814/23970
dc.description (Published version of EUI PhD thesis, 2006.) en
dc.description.abstract The production of medicines, pharmaceutical and herbal, involves the sourcing of both genetic resources in the natural environment, and local knowledge. Sourcing substances for medicines in the natural environment is known as biodiversity prospecting or bioprospecting . To ensure that benefits resulting from medicinal bioprospecting are brought to those ultimately bearing the costs of conservation and sustainable use, there must be a focus on indigenous peoples rights particularly property rights, whether to land, genetic material, intellectual property, or traditional medicinal knowledge. This study considers the importance of access and benefit-sharing agreements as incentives for biodiversity protection. It analyses the meaning of the objectives set by the Convention on Biological Diversity (CBD) for its implementation, examines selected domestic access and benefit-sharing measures and industry practices and, finally, evaluates the discussions taking place in international fora regarding the Convention and its principles. Finally, it attempts to make recommendations on how to realize the objective of the Convention for fair and equitable benefit-sharing, focusing on enhanced protection of indigenous peoples rights. en
dc.description.tableofcontents --The issue and the approach of the study --Convention on biological diversities-principles --Access and benefit-sharing in the CBD-Bonn guidelines --The international debate on the emrging ABS regime-FAO, WTO and WIPO --Selected domestic snd regional implementation --Private practice in bioprospecting --Policy evaluation en
dc.language.iso en en
dc.publisher British Institute of International and Comparative Law en
dc.title Medicinal Bioprospecting: Policy options for access and benefit-sharing en
dc.type Book en


Files in this item

This item appears in the following Collection(s)

Show simple item record